Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) just unveiled an update.
EZZ Life Science Holdings Limited has announced a fully franked final dividend of $0.020 per share for the fiscal year ending 30 June 2025. The dividend will be paid on 23 December 2025, with an ex-dividend date of 24 November 2025 and a record date of 25 November 2025. This announcement reflects the company’s commitment to rewarding shareholders and may enhance its attractiveness to investors.
The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is a genomic life science company focused on improving quality of life and human health through research and development in gene technology. The company addresses key health challenges such as genetic longevity, HPV, children’s health, and weight management. EZZ Life develops and distributes high-quality health and wellness products, including functional foods, across Australia, New Zealand, China, and globally through omnichannel models.
Average Trading Volume: 88,201
Technical Sentiment Signal: Buy
Current Market Cap: A$105.2M
Find detailed analytics on EZZ stock on TipRanks’ Stock Analysis page.